Disclosure Plus

KPM TECH CO., LTD. Decides on 225억 원 Third-Party Allotment Capital Increase

[Edaily Reporter Park Sun-Yeop ] KPM TECH CO., LTD.(042040)announced on the 3rd that it has decided to conduct a third-party private placement worth 22.4999 billion won targeting its largest shareholder, Telcon RF Pharmaceuticals.
A total of 6,200,055 common shares will be issued. The issue price is 3,629 won per share, and the shares are scheduled to be listed on the 27th. The payment date is the 13th.
Of the funds raised, 8 billion won will be used to repay debt, and 14.4999 billion won will be used to acquire securities of other companies. The funds for acquiring securities of other companies are planned to be used to acquire shares of NUON.
The proceeds from this new share issuance will be paid through a combination of a cash payment of 14.4999 billion won from Telcon RF Pharmaceuticals and a substitute payment of 8 billion won in the form of borrowed funds. The company borrowed 6 billion won from Telcon RF Pharmaceuticals on March 31 and 2 billion won on April 27.
Prior to the capital increase, KPM TECH CO., LTD.’s total number of issued shares was 2,470,936 common shares. The new shares issued through this capital increase will be subject to a one-year lock-up period starting from the date of certificate issuance.

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02